Please be advised that the site will be down for maintenance on Sunday, September 1, 2024, from 08:00 to 18:00, and again on Monday, September 2, 2024, from 08:00 to 09:00. We apologize for any inconvenience this may cause.
dc.contributor.author | Balogun, Mohammed Olusegun![]() |
|
dc.contributor.author | Huws, Enlli![]() |
|
dc.contributor.author | Sirhan, Muthana M.![]() |
|
dc.contributor.author | Saleh, Ahmed D.![]() |
|
dc.contributor.author | Al Dulayymi, Juma’a R.![]() |
|
dc.contributor.author | Pilcher, Lynne A.![]() |
|
dc.contributor.author | Verschoor, J.A. (Jan Adrianus), 1953-![]() |
|
dc.contributor.author | Baird, Mark S.![]() |
|
dc.date.accessioned | 2017-02-28T11:17:18Z | |
dc.date.available | 2017-02-28T11:17:18Z | |
dc.date.issued | 2013-07 | |
dc.description.abstract | Patient serum antibodies to mycolic acids have the potential to be surrogate markers of active tuberculosis (TB) when they can be distinguished from the ubiquitously present cross-reactive antibodies to cholesterol. Mycolic acids are known to interact more strongly with antibodies present in the serum of patients with active TB than in patients with latent TB or no TB. Examples of single stereoisomers of mycolic acids with chain lengths corresponding to major homologues of those present in Mycobacterium tuberculosis have now been synthesised with a sulfur substituent on the terminal position of the -chain; initial studies have established that one of these binds to a gold electrode surface, offering the potential to develop second generation sensors for diagnostic patient antibody detection. | en_ZA |
dc.description.department | Biochemistry | en_ZA |
dc.description.department | Chemistry | en_ZA |
dc.description.librarian | hb2017 | en_ZA |
dc.description.sponsorship | MMS and ADS wish to acknowledge support from the Government of Iraq through the award of PhD studentships. | en_ZA |
dc.description.uri | http://www.elsevier.com/locate/chemphyslip | en_ZA |
dc.identifier.citation | Balogun, MO, Huws, EH, Sirhan, MM, Saleh, AD, Al Dulayymi, JR, Pilcher, L, Verschoor, JA & Baird, MS 2013, 'Thiol modified mycolic acids', Chemistry and Physics of Lipids, vol. 172-173, pp. 40-55. | en_ZA |
dc.identifier.issn | 0009-3084 (print) | |
dc.identifier.issn | 1873-2941 (online) | |
dc.identifier.other | 10.1016/j.chemphyslip.2013.03.004 | |
dc.identifier.uri | http://hdl.handle.net/2263/59198 | |
dc.language.iso | en | en_ZA |
dc.publisher | Elsevier | en_ZA |
dc.rights | © 2013 Elsevier Ireland Ltd. All rights reserved. Notice : this is the author’s version of a work that was accepted for publication in Chemistry and Physics of Lipids. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. A definitive version was subsequently published in Chemistry and Physics of Lipids, vol. 172-173, pp. 40-55, 2013. doi : 10.1016/j.chemphyslip.2013.03.004. | en_ZA |
dc.subject | Mycolic acids | en_ZA |
dc.subject | Thiolated | en_ZA |
dc.subject | Gold surfaces | en_ZA |
dc.subject | Cyclic voltammetry | en_ZA |
dc.subject | Tuberculosis (TB) | en_ZA |
dc.title | Thiol modified mycolic acids | en_ZA |
dc.type | Postprint Article | en_ZA |